| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Diamond-Blackfan | 19 | 2020 | 141 | 3.490 |
Why?
|
| Ribosomal Proteins | 14 | 2018 | 361 | 1.500 |
Why?
|
| Bone Marrow Diseases | 5 | 2018 | 240 | 1.450 |
Why?
|
| Anemia, Aplastic | 7 | 2018 | 236 | 1.410 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2018 | 98 | 1.340 |
Why?
|
| Colony-Stimulating Factors | 18 | 1994 | 221 | 1.120 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 598 | 0.950 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2005 | 113 | 0.880 |
Why?
|
| Hematopoietic Stem Cells | 33 | 2019 | 3447 | 0.880 |
Why?
|
| Interleukin-3 | 18 | 2005 | 439 | 0.860 |
Why?
|
| Hematopoiesis | 22 | 2019 | 2015 | 0.810 |
Why?
|
| Fanconi Anemia | 7 | 2001 | 326 | 0.750 |
Why?
|
| Erythropoiesis | 15 | 2017 | 708 | 0.740 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2016 | 14 | 0.640 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2016 | 114 | 0.610 |
Why?
|
| Receptors, Erythropoietin | 5 | 1997 | 146 | 0.600 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2016 | 113 | 0.580 |
Why?
|
| Bone Marrow | 15 | 2019 | 2938 | 0.560 |
Why?
|
| Mutation | 17 | 2019 | 29262 | 0.500 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 519 | 0.490 |
Why?
|
| Hematopoietic Cell Growth Factors | 6 | 1993 | 104 | 0.460 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 15 | 1998 | 903 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2018 | 1255 | 0.390 |
Why?
|
| Tissue Donors | 3 | 2018 | 2147 | 0.370 |
Why?
|
| Bone Marrow Cells | 18 | 2006 | 2596 | 0.370 |
Why?
|
| Antigens, CD34 | 10 | 2019 | 673 | 0.320 |
Why?
|
| Granulocytes | 9 | 2019 | 562 | 0.290 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5135 | 0.290 |
Why?
|
| Growth Substances | 10 | 1994 | 812 | 0.290 |
Why?
|
| Erythropoietin | 8 | 2005 | 731 | 0.280 |
Why?
|
| Neutrophils | 2 | 2016 | 3867 | 0.270 |
Why?
|
| Antigens, Surface | 6 | 1986 | 1858 | 0.270 |
Why?
|
| Recombinant Proteins | 16 | 1997 | 6850 | 0.260 |
Why?
|
| Anemia, Sideroblastic | 3 | 2018 | 101 | 0.260 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2018 | 3281 | 0.250 |
Why?
|
| GATA1 Transcription Factor | 3 | 2014 | 300 | 0.230 |
Why?
|
| Erythroid Precursor Cells | 5 | 2006 | 226 | 0.230 |
Why?
|
| Interleukin-1 | 6 | 1991 | 1276 | 0.220 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 79 | 0.220 |
Why?
|
| Receptors, Virus | 2 | 2005 | 628 | 0.200 |
Why?
|
| Cells, Cultured | 23 | 2015 | 20170 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 5 | 1998 | 3878 | 0.200 |
Why?
|
| Cell Division | 12 | 1999 | 4752 | 0.200 |
Why?
|
| Colony-Forming Units Assay | 13 | 2000 | 372 | 0.190 |
Why?
|
| Antigens, CD | 6 | 2015 | 4169 | 0.190 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 1999 | 31 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2019 | 2503 | 0.190 |
Why?
|
| Leucine | 2 | 2020 | 591 | 0.190 |
Why?
|
| Gene Expression Regulation | 9 | 2006 | 12447 | 0.190 |
Why?
|
| Moloney murine leukemia virus | 1 | 1999 | 137 | 0.180 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1999 | 101 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 466 | 0.180 |
Why?
|
| Gene Transfer Techniques | 3 | 2000 | 1299 | 0.180 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2019 | 71 | 0.180 |
Why?
|
| Spectrin | 1 | 2019 | 174 | 0.180 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2018 | 12 | 0.180 |
Why?
|
| Portraits as Topic | 1 | 2018 | 33 | 0.180 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 188 | 0.170 |
Why?
|
| MELAS Syndrome | 1 | 2018 | 52 | 0.170 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 27 | 0.170 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 444 | 0.160 |
Why?
|
| Receptors, Transferrin | 3 | 2015 | 275 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2005 | 1939 | 0.160 |
Why?
|
| Acidosis, Lactic | 1 | 2018 | 128 | 0.160 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 749 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 616 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 4065 | 0.150 |
Why?
|
| Capsid | 1 | 1999 | 441 | 0.150 |
Why?
|
| Siblings | 2 | 2018 | 806 | 0.150 |
Why?
|
| Thrombophilia | 1 | 2019 | 318 | 0.150 |
Why?
|
| Humans | 105 | 2021 | 708843 | 0.150 |
Why?
|
| RNA Interference | 1 | 2005 | 3026 | 0.140 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 589 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 247 | 0.140 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1246 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 647 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2019 | 877 | 0.130 |
Why?
|
| RNA, Ribosomal | 2 | 2013 | 254 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4941 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 622 | 0.130 |
Why?
|
| Methionine | 1 | 2016 | 600 | 0.130 |
Why?
|
| Cell Differentiation | 16 | 2019 | 11718 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2018 | 381 | 0.130 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1993 | 45 | 0.130 |
Why?
|
| Vitamin B 12 | 1 | 2016 | 512 | 0.120 |
Why?
|
| Stem Cell Factor | 3 | 2005 | 223 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 2164 | 0.120 |
Why?
|
| Homocysteine | 1 | 2016 | 660 | 0.120 |
Why?
|
| Arthroscopy | 1 | 2019 | 824 | 0.120 |
Why?
|
| Hip Joint | 1 | 2019 | 932 | 0.110 |
Why?
|
| Pedigree | 6 | 2015 | 4724 | 0.110 |
Why?
|
| Ribosomes | 3 | 2018 | 517 | 0.110 |
Why?
|
| RNA, Messenger | 11 | 2014 | 13314 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 990 | 0.110 |
Why?
|
| Cell Line | 11 | 2008 | 16657 | 0.110 |
Why?
|
| Genetic Linkage | 4 | 2006 | 2521 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1726 | 0.100 |
Why?
|
| Cell Cycle | 3 | 1999 | 3014 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 1067 | 0.100 |
Why?
|
| Receptors, Colony-Stimulating Factor | 4 | 1994 | 47 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 1986 | 1537 | 0.100 |
Why?
|
| Genes, myb | 1 | 2009 | 20 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 1999 | 3812 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1730 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 397 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 2971 | 0.100 |
Why?
|
| T-Lymphocytes | 11 | 1999 | 10362 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2018 | 2838 | 0.090 |
Why?
|
| Globins | 3 | 2017 | 444 | 0.090 |
Why?
|
| Exons | 2 | 2018 | 2472 | 0.090 |
Why?
|
| Infant | 14 | 2018 | 34261 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 8 | 2000 | 2789 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1999 | 3563 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3645 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1728 | 0.090 |
Why?
|
| Leukemia | 5 | 1997 | 1496 | 0.090 |
Why?
|
| Transfection | 5 | 1996 | 6161 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2017 | 1066 | 0.090 |
Why?
|
| G1 Phase | 1 | 2009 | 422 | 0.090 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 18748 | 0.090 |
Why?
|
| Glycoproteins | 3 | 1987 | 2309 | 0.090 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 4317 | 0.090 |
Why?
|
| Base Sequence | 6 | 2012 | 13352 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2019 | 23950 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1988 | 4466 | 0.080 |
Why?
|
| Animals | 33 | 2015 | 170486 | 0.080 |
Why?
|
| Fibroblasts | 6 | 2015 | 4299 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 586 | 0.080 |
Why?
|
| Thumb | 1 | 2008 | 229 | 0.080 |
Why?
|
| Mice | 18 | 2006 | 80876 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4677 | 0.080 |
Why?
|
| Erythroblasts | 3 | 1999 | 162 | 0.080 |
Why?
|
| Haplotypes | 2 | 2004 | 2874 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2502 | 0.070 |
Why?
|
| Clone Cells | 4 | 1999 | 1767 | 0.070 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1983 | 198 | 0.070 |
Why?
|
| Endothelium, Vascular | 3 | 1988 | 4658 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 989 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2019 | 8720 | 0.070 |
Why?
|
| Mesoderm | 1 | 1988 | 728 | 0.070 |
Why?
|
| Interleukins | 1 | 1990 | 799 | 0.070 |
Why?
|
| Erythrocytes | 6 | 1987 | 2418 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 5 | 1997 | 637 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 1377 | 0.070 |
Why?
|
| Stem Cells | 4 | 2005 | 3593 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 5456 | 0.070 |
Why?
|
| Retroviridae | 2 | 2005 | 957 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2009 | 10803 | 0.060 |
Why?
|
| Macrophages | 5 | 1995 | 5784 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 2012 | 1636 | 0.060 |
Why?
|
| Endothelium | 1 | 1987 | 810 | 0.060 |
Why?
|
| Cell Separation | 8 | 2006 | 1835 | 0.060 |
Why?
|
| Cleft Palate | 1 | 2008 | 500 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 1993 | 1578 | 0.060 |
Why?
|
| Osteopetrosis | 1 | 1983 | 45 | 0.060 |
Why?
|
| Fibronectins | 1 | 1987 | 734 | 0.060 |
Why?
|
| K562 Cells | 1 | 2005 | 640 | 0.060 |
Why?
|
| RNA | 2 | 2009 | 2680 | 0.060 |
Why?
|
| Drug Synergism | 4 | 1994 | 1875 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2019 | 2630 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 766 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 10 | 1994 | 9584 | 0.060 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 2709 | 0.060 |
Why?
|
| Monocytes | 5 | 2019 | 2660 | 0.060 |
Why?
|
| Male | 29 | 2020 | 349524 | 0.060 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4293 | 0.060 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1981 | 89 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 1015 | 0.060 |
Why?
|
| Flow Cytometry | 6 | 2005 | 6127 | 0.050 |
Why?
|
| Cations | 1 | 2021 | 242 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1123 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 2100 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 4837 | 0.050 |
Why?
|
| Lod Score | 1 | 2001 | 617 | 0.050 |
Why?
|
| Receptors, Cell Surface | 4 | 2000 | 2913 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 2040 | 0.050 |
Why?
|
| Dyskeratosis Congenita | 1 | 2000 | 74 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4226 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 373 | 0.050 |
Why?
|
| Killer Cells, Natural | 4 | 1999 | 2165 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1024 | 0.050 |
Why?
|
| Cell Membrane | 3 | 1987 | 3892 | 0.050 |
Why?
|
| Permeability | 1 | 2021 | 791 | 0.050 |
Why?
|
| Female | 27 | 2020 | 375205 | 0.050 |
Why?
|
| Cyclophosphamide | 3 | 1997 | 2189 | 0.050 |
Why?
|
| Reference Values | 1 | 2006 | 5041 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2006 | 15274 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 255 | 0.040 |
Why?
|
| Primary Myelofibrosis | 1 | 1980 | 199 | 0.040 |
Why?
|
| Liver | 3 | 2009 | 7622 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2000 | 360 | 0.040 |
Why?
|
| Phenotype | 7 | 2018 | 16306 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 1989 | 200 | 0.040 |
Why?
|
| Adolescent | 12 | 2020 | 84718 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 14215 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2012 | 21194 | 0.040 |
Why?
|
| Blood Specimen Collection | 2 | 1997 | 248 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8896 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 26 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1999 | 351 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 340 | 0.040 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2019 | 318 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3093 | 0.040 |
Why?
|
| Interleukin-2 | 5 | 1996 | 1936 | 0.040 |
Why?
|
| Culture Media | 3 | 1989 | 958 | 0.040 |
Why?
|
| Thymidine | 1 | 1996 | 352 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 7965 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1996 | 99 | 0.040 |
Why?
|
| Bone Marrow Purging | 2 | 1996 | 113 | 0.040 |
Why?
|
| Janus Kinase 2 | 2 | 1996 | 508 | 0.040 |
Why?
|
| Time Factors | 7 | 2005 | 41038 | 0.040 |
Why?
|
| Child, Preschool | 9 | 2020 | 41081 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 2000 | 828 | 0.040 |
Why?
|
| Blood Component Removal | 1 | 1997 | 118 | 0.040 |
Why?
|
| Child | 14 | 2020 | 73636 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 473 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2013 | 3258 | 0.040 |
Why?
|
| Neutropenia | 1 | 2000 | 871 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2010 | 446 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 1996 | 176 | 0.040 |
Why?
|
| Heterozygote | 2 | 2019 | 2780 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 1981 | 591 | 0.040 |
Why?
|
| Erythroid Cells | 1 | 2017 | 252 | 0.030 |
Why?
|
| Stromal Cells | 2 | 1998 | 1361 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1996 | 372 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2125 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2000 | 1135 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4353 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2926 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1095 | 0.030 |
Why?
|
| Platelet Count | 2 | 1998 | 794 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3507 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1981 | 1814 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 1994 | 59 | 0.030 |
Why?
|
| Syndrome | 1 | 2000 | 3177 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2001 | 2690 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 1918 | 0.030 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 2 | 1986 | 152 | 0.030 |
Why?
|
| HLA Antigens | 4 | 1986 | 1549 | 0.030 |
Why?
|
| Lymphocytes | 7 | 1998 | 2729 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1994 | 674 | 0.030 |
Why?
|
| Isoantigens | 1 | 1996 | 579 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 22989 | 0.030 |
Why?
|
| Aftercare | 1 | 2019 | 689 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5982 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 436 | 0.030 |
Why?
|
| Graft vs Host Disease | 3 | 1996 | 2818 | 0.030 |
Why?
|
| Mice, SCID | 1 | 1999 | 2835 | 0.030 |
Why?
|
| Tyrosine | 2 | 1996 | 1477 | 0.030 |
Why?
|
| Adult | 17 | 2020 | 211041 | 0.030 |
Why?
|
| Apoptosis | 2 | 2008 | 10085 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 1995 | 1670 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 1418 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2000 | 24433 | 0.030 |
Why?
|
| DNA | 4 | 2008 | 7172 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1956 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 520 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 513 | 0.030 |
Why?
|
| Genomic Library | 1 | 1991 | 198 | 0.030 |
Why?
|
| Young Adult | 4 | 2020 | 55940 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 759 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1993 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 3 | 1991 | 539 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 1018 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 1996 | 1001 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1998 | 1136 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 1994 | 671 | 0.030 |
Why?
|
| Blood Proteins | 3 | 1986 | 1144 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1756 | 0.030 |
Why?
|
| Sialoglycoproteins | 2 | 1983 | 370 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 4883 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 704 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2013 | 826 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 2427 | 0.030 |
Why?
|
| North America | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2440 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3209 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1993 | 2673 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1996 | 1303 | 0.020 |
Why?
|
| Graft Survival | 2 | 1999 | 3767 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 1990 | 3245 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1516 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1134 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1719 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1995 | 679 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 2461 | 0.020 |
Why?
|
| Quinazolines | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1990 | 180 | 0.020 |
Why?
|
| Ribosome Subunits, Large | 1 | 2008 | 5 | 0.020 |
Why?
|
| Ribosome Subunits, Small | 1 | 2008 | 5 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1994 | 2064 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1996 | 831 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 3053 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 1998 | 9774 | 0.020 |
Why?
|
| Phagocytes | 1 | 1990 | 306 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1993 | 1634 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1897 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1687 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1343 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39038 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1998 | 11239 | 0.020 |
Why?
|
| Cell Survival | 1 | 1999 | 6156 | 0.020 |
Why?
|
| Hylobates | 1 | 1987 | 14 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 4057 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1330 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2001 | 3303 | 0.020 |
Why?
|
| Estrogens | 1 | 1995 | 1511 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 343 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1988 | 889 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9907 | 0.020 |
Why?
|
| Prognosis | 3 | 2020 | 28919 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1995 | 1412 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 7994 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 327 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1988 | 336 | 0.020 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 1537 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18375 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2144 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2006 | 60 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 1403 | 0.020 |
Why?
|
| Nucleoside Transport Proteins | 1 | 1986 | 9 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1988 | 438 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6293 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2006 | 83 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1987 | 452 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1994 | 2035 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1988 | 412 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1986 | 258 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1593 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 489 | 0.020 |
Why?
|
| Giant Cell Tumors | 1 | 1986 | 99 | 0.020 |
Why?
|
| Point Mutation | 2 | 2005 | 1656 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1991 | 1782 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 227 | 0.020 |
Why?
|
| Proteins | 2 | 1998 | 6151 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 2 | 1981 | 1241 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1986 | 385 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 1482 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1971 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 3026 | 0.020 |
Why?
|
| Blood Group Antigens | 1 | 1986 | 171 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7189 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1894 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5908 | 0.020 |
Why?
|
| Cricetulus | 1 | 1986 | 857 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 1026 | 0.020 |
Why?
|
| Protein Binding | 1 | 1996 | 9639 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2019 | 4293 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 981 | 0.020 |
Why?
|
| Heme | 1 | 2005 | 297 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 526 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1380 | 0.020 |
Why?
|
| I Blood-Group System | 1 | 1982 | 8 | 0.020 |
Why?
|
| Kinetics | 1 | 1991 | 6796 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1983 | 222 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2006 | 777 | 0.010 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1983 | 101 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 681 | 0.010 |
Why?
|
| Placenta | 1 | 1991 | 1502 | 0.010 |
Why?
|
| Receptors, Fc | 2 | 1989 | 562 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1977 | 0.010 |
Why?
|
| Cricetinae | 1 | 1986 | 2588 | 0.010 |
Why?
|
| X Chromosome | 3 | 1995 | 817 | 0.010 |
Why?
|
| Tumor Virus Infections | 2 | 1981 | 453 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4861 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 3773 | 0.010 |
Why?
|
| Middle Aged | 8 | 2020 | 213752 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 39292 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4489 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 1021 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 534 | 0.010 |
Why?
|
| Forearm | 1 | 1983 | 406 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1982 | 696 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1988 | 2264 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1276 | 0.010 |
Why?
|
| Antigens, Differentiation | 2 | 1996 | 959 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1997 | 422 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1982 | 359 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2000 | 150 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 61932 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1986 | 1673 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2000 | 129 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10019 | 0.010 |
Why?
|
| Karyotyping | 1 | 1981 | 1269 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3318 | 0.010 |
Why?
|
| Rosette Formation | 3 | 1986 | 187 | 0.010 |
Why?
|
| Cell Communication | 1 | 1986 | 1653 | 0.010 |
Why?
|
| Immune Sera | 1 | 1998 | 702 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 102 | 0.010 |
Why?
|
| Mitomycin | 1 | 1998 | 247 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 20172 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2000 | 499 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1990 | 762 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 681 | 0.010 |
Why?
|
| Epitopes | 2 | 1981 | 2646 | 0.010 |
Why?
|
| Hematocrit | 1 | 1998 | 636 | 0.010 |
Why?
|
| Cell Count | 2 | 1995 | 1920 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 107 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 614 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1995 | 128 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 198 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1997 | 953 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.010 |
Why?
|
| Immunization | 1 | 1980 | 1273 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1995 | 12005 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 6571 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 276 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1996 | 367 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1983 | 4831 | 0.010 |
Why?
|
| Rabbits | 1 | 1981 | 5163 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 1374 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1995 | 209 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 222 | 0.010 |
Why?
|
| Antibodies, Viral | 2 | 1981 | 2930 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 2473 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 875 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 2619 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1981 | 2003 | 0.010 |
Why?
|
| Genome, Human | 1 | 2006 | 4493 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1148 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1981 | 4422 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 1611 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1997 | 882 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 69553 | 0.010 |
Why?
|
| Tretinoin | 1 | 1995 | 527 | 0.010 |
Why?
|
| Radiography | 1 | 1983 | 6989 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1990 | 18 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1991 | 486 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1997 | 2427 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1991 | 264 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1995 | 2092 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 26832 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 5045 | 0.010 |
Why?
|
| Superoxides | 1 | 1990 | 386 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 638 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1977 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1990 | 661 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1994 | 1620 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 850 | 0.010 |
Why?
|
| Fetus | 2 | 1986 | 1828 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1060 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1986 | 8072 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 19423 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1449 | 0.010 |
Why?
|
| Swine | 1 | 1997 | 5763 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1987 | 288 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1983 | 4057 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1991 | 1419 | 0.000 |
Why?
|
| Tritium | 1 | 1987 | 812 | 0.000 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1986 | 132 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1989 | 612 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 1499 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2303 | 0.000 |
Why?
|
| Fetal Hemoglobin | 1 | 1987 | 331 | 0.000 |
Why?
|
| Interferon Type I | 1 | 1987 | 498 | 0.000 |
Why?
|
| Thioguanine | 1 | 1983 | 56 | 0.000 |
Why?
|
| Daunorubicin | 1 | 1983 | 152 | 0.000 |
Why?
|
| Photomicrography | 1 | 1981 | 75 | 0.000 |
Why?
|
| Aged | 3 | 2005 | 161488 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 997 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1996 | 3344 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1981 | 143 | 0.000 |
Why?
|
| Cytarabine | 1 | 1983 | 689 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 366 | 0.000 |
Why?
|
| Agammaglobulinemia | 1 | 1981 | 177 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1987 | 1334 | 0.000 |
Why?
|
| Antigens | 1 | 1986 | 1507 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 4712 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 13714 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1981 | 952 | 0.000 |
Why?
|
| Interferons | 1 | 1981 | 667 | 0.000 |
Why?
|
| Skin | 1 | 1991 | 4325 | 0.000 |
Why?
|
| Sheep | 1 | 1980 | 1484 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1981 | 1153 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1981 | 1527 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1981 | 1693 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 10525 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 12183 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1983 | 6562 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 19800 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1981 | 2937 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1983 | 11126 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1981 | 8992 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1983 | 8024 | 0.000 |
Why?
|